Effects of Steady-State Lopinavir/Ritonavir on the Pharmacokinetics of Pitavastatin in Healthy Adult VolunteersMORGAN, Roger E; CAMPBELL, Stuart E; SUEHIRA, Kazuhito et al.Journal of acquired immune deficiency syndromes (1999). 2012, Vol 60, Num 2, pp 158-164, issn 1525-4135, 7 p.Article

Pharmacokinetics of Lopinavir/Ritonavir Crushed Versus Whole Tablets in ChildrenBEST, Brookie M; CAPPARELLI, Edmund V; DIEP, Huy et al.Journal of acquired immune deficiency syndromes (1999). 2011, Vol 58, Num 4, pp 385-391, issn 1525-4135, 7 p.Article

Coadministration of esomeprazole with fosamprenavir has no impact on steady-state plasma amprenavir pharmacokineticsSHELTON, Mark J; FORD, Susan L; BORLAND, Julie et al.Journal of acquired immune deficiency syndromes (1999). 2006, Vol 42, Num 1, pp 61-67, issn 1525-4135, 7 p.Article

Influence of Low-Dose Ritonavir With and Without Darunavir on the Pharmacokinetics and Pharmacodynamics of Inhaled BeclomethasoneBOYD, Sarita D; HADIGAN, Colleen; MCMANUS, Maryellen et al.Journal of acquired immune deficiency syndromes (1999). 2013, Vol 63, Num 3, pp 355-361, issn 1525-4135, 7 p.Article

A Lopinavir/Ritonavir-Based Once-Daily Regimen Results in Better Compliance and Is Non-inferior to a Twice-Daily Regimen Through 96 WeeksMOLINA, Jean-Michel; PODSADECKI, Thomas J; JOHNSON, Margaret A et al.AIDS research and human retroviruses. 2007, Vol 23, Num 12, pp 1505-1514, issn 0889-2229, 10 p.Article

Pharmacokinetics and safety of tenofovir disoproxil fumarate on coadministration with lopinavir/ritonavirKEARNEY, Brian P; MATHIAS, Anita; MITTAN, Angelique et al.Journal of acquired immune deficiency syndromes (1999). 2006, Vol 43, Num 3, pp 278-283, issn 1525-4135, 6 p.Article

Beneficial pharmacokinetic interaction between atazanavir and lopinavir/ritonavirPHAM, Paul A; FLEXNER, Charles; PARSONS, Teresa et al.Journal of acquired immune deficiency syndromes (1999). 2007, Vol 45, Num 2, pp 201-205, issn 1525-4135, 5 p.Article

Long-term immunologic outcome in HAART-experienced subjects receiving lopinavir/ritonavirBONGIOVANNI, Marco; BINI, Teresa; CASANA, Maddalena et al.AIDS research and human retroviruses. 2006, Vol 22, Num 11, pp 1099-1105, issn 0889-2229, 7 p.Article

Plasma and Intracellular Pharmacokinetics of Darunavir/ Ritonavir Once Daily and Raltegravir Once and Twice Daily in HIV-Infected IndividualsJACKSON, Akil; WATSON, Victoria; BOFFITO, Marta et al.Journal of acquired immune deficiency syndromes (1999). 2011, Vol 58, Num 5, pp 450-457, issn 1525-4135, 8 p.Article

Simultaneous Population Pharmacokinetic Modelling of Atazanavir and Ritonavir in HIV-Infected Adults and Assessment of Different Dose Reduction StrategiesSCHIPANI, Alessandro; DICKINSON, Laura; BOFFITO, Marta et al.Journal of acquired immune deficiency syndromes (1999). 2013, Vol 62, Num 1, pp 60-66, issn 1525-4135, 7 p.Article

Drug/Drug Interaction Between Lopinavir/Ritonavir and Rosuvastatin in Healthy VolunteersKISER, Jennifer J; GERBER, John G; PREDHOMME, Julie A et al.Journal of acquired immune deficiency syndromes (1999). 2008, Vol 47, Num 5, pp 570-578, issn 1525-4135, 9 p.Article

The tablet formulation of lopinavir/ritonavir provides similar bioavailability to the soft-gelatin capsule formulation with less pharmacokinetic variability and diminished food effectENDERS KLEIN, Cheri; CHIU, Yi-Lin; AWNI, Walid et al.Journal of acquired immune deficiency syndromes (1999). 2007, Vol 44, Num 4, pp 401-410, issn 1525-4135, 10 p.Article

Effect of Ritonavir-Boosted Tipranavir or Darunavir on the Steady-State Pharmacokinetics of ElvitegravirMATHIAS, Anita A; HINKLE, John; GONG SHEN et al.Journal of acquired immune deficiency syndromes (1999). 2008, Vol 49, Num 2, pp 156-162, issn 1525-4135, 7 p.Article

Steady-State Pharmacokinetics of Lopinavir Plus Ritonavir When Administered Under Different Meal Conditions in HIV-Infected Ugandan AdultsLAMORDE, Mohammed; BYAKIKA-KIBWIKA, Pauline; MERRY, Concepta et al.Journal of acquired immune deficiency syndromes (1999). 2012, Vol 60, Num 3, pp 295-298, issn 1525-4135, 4 p.Article

Hepatotoxicity and Gastrointestinal Intolerance When Healthy Volunteers Taking Rifampin Add Twice-Daily Atazanavir and RitonavirHAAS, David W; KOLETAR, Susan L; ALSTON-SMITH, Beverly et al.Journal of acquired immune deficiency syndromes (1999). 2009, Vol 50, Num 3, pp 290-293, issn 1525-4135, 4 p.Article

Deep salvage with amprenavir and lopinavir/ritonavir: Correlation of pharmacokinetics and drug resistance with pharmacodynamicsDE LUCA, Andrea; BALDINI, Francesco; CINGOLANI, Antonella et al.Journal of acquired immune deficiency syndromes (1999). 2004, Vol 35, Num 4, pp 359-366, issn 1525-4135, 8 p.Article

Switch from Ritonavir-Boosted to Unboosted Atazanavir Guided by Therapeutic Drug MonitoringRODRIGUEZ-NOVOA, Sonia; MORELLO, Judit; BARREIRO, Pablo et al.AIDS research and human retroviruses. 2008, Vol 24, Num 6, pp 821-825, issn 0889-2229, 5 p.Article

Early virologic rebound in a pilottrial of ritonavir-boosted atazanavir as maintenance monotherapyKARLSTRÖM, Olle; JOSEPHSON, Filip; SÖNNERBORG, Anders et al.Journal of acquired immune deficiency syndromes (1999). 2007, Vol 44, Num 4, pp 417-422, issn 1525-4135, 6 p.Article

Gemfibrozil ConcentrationsAre Significantly Decreased in the Presence of Lopinavir-RitonavirBUSSE, Kristin H; HADIGAN, Colleen; CHAIREZ, Cheryl et al.Journal of acquired immune deficiency syndromes (1999). 2009, Vol 52, Num 2, pp 235-239, issn 1525-4135, 5 p.Conference Paper

Pharmacokinetic Interaction of Ritonavir-Boosted Elvitegravir and MaravirocRAMANATHAN, Srinivasan; ABEL, Samantha; TWEEDY, Sarah et al.Journal of acquired immune deficiency syndromes (1999). 2010, Vol 53, Num 2, pp 209-214, issn 1525-4135, 6 p.Article

Comparison of Once-Daily Fosamprenavir Boosted with Either 100 or 200 mg of Ritonavir, in Combination with Abacavir/Lamivudine : 96-Week Results from COL100758HICKS, Charles B; DEJESUS, Edwin; SLOAN, Louis M et al.AIDS research and human retroviruses. 2009, Vol 25, Num 4, pp 395-403, issn 0889-2229, 9 p.Article

Lopinavir-ritonavir : Effects on endothelial cell function in healthy subjectsGRUBB, Jessica R; DEJAM, André; VOELL, Jocelyn et al.The Journal of infectious diseases. 2006, Vol 193, Num 11, pp 1516-1519, issn 0022-1899, 4 p.Article

Dystrophie unguéale médiane et ritonavir = Median nail dystrophy and ritonavirSCHMUTZ, J.-L; TRECHOT, P.Annales de dermatologie et de vénéréologie. 2014, Vol 141, Num 6-7, pp 485-486, issn 0151-9638, 2 p.Article

Beneficial Effects of a Switch to a Lopinavir/ritonavir-Containing Regimen for Patients with Partial or No Immune Reconstitution with Highly Active Antiretroviral Therapy Despite Complete Viral SuppressionPITRAK, D. L; ESTES, R; NOVAK, R. M et al.AIDS research and human retroviruses. 2011, Vol 27, Num 6, pp 659-667, issn 0889-2229, 9 p.Article

Early ritonavir-induced maculopapular eruptionBACHMEYER, C; BLUM, L; CORDIER, F et al.Dermatology (Basel). 1997, Vol 195, Num 3, pp 301-302, issn 1018-8665Article